Table 4.

Association of Different Baseline and In‐Trial Factors With Change in ASBPV in Simple Linear Regression Analysis

	Coefficient	95% Confidence Interval		P Value
		Lower	Upper
Change in 24‐h SBP (per mm Hg/y)	0.06	0.03	0.08	<0.001
Age 75 y or more (vs <75 y)	−0.08	−0.47	0.31	0.67
Male (vs female)	0.53	0.19	0.88	0.003
Previous history of heart disease	−0.18	−0.72	0.35	0.50
Previous history of antihypertensive use	−0.25	−0.62	0.12	0.19
eGFR (per mL/min/1.73 m2)	0.01	−0.005	0.02	0.23
Low HDL	0.30	−0.22	0.83	0.26
Raised cholesterol	−0.10	−0.53	0.32	0.64
Active smoker	1.01	0.23	1.79	0.01
Active drinker	0.53	0.11	0.95	0.01
Diabetes mellitus	0.05	−0.67	0.77	0.90
Depression	−0.42	−1.23	0.38	0.30
Exercise in previous 2 wk
None	Ref
1–6 h	−0.14	−0.60	0.33	0.56
≥7 h	−0.09	−0.51	0.33	0.68
ACEI (vs diuretic)	0.30	−0.04	0.65	0.08
No. of BP‐lowering medications used
1	Ref
≥2	−0.13	−0.49	0.22	0.45
None	−0.06	−0.95	0.83	0.90

ACEI indicates angiotensin‐converting enzyme inhibitor; ASBPV, ambulatory systolic blood pressure variability; BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; Ref, referent; SBP, systolic blood pressure.